Is the ISGPS definition of pancreatic fistula applicable after gastrectomy?

Background Pancreatic fistula is one of the most common and potentially fatal surgical complications after radical gastrectomy. The purpose of this study was to assess the validity of extrapolating the definition of pancreatic fistula by the International Study Group on Pancreatic Surgery to include...

Full description

Saved in:
Bibliographic Details
Published in:International journal of clinical oncology 2022-08, Vol.27 (8), p.1273-1278
Main Authors: Wakahara, Tomoyuki, Miura, Susumu, Yasuhara, Yuki, Mukubo, Hideyo, Kanemitsu, Kiyonori, Iwasaki, Takeshi, Sasako, Mitsuru
Format: Article
Language:English
Subjects:
Cancer Research
Cancer surgery
Fistula
Fistulae
Gastrectomy
Gastric cancer
Gastrointestinal surgery
Lymph nodes
Medicine
Medicine & Public Health
Oncology
Original Article
Pancreas
Pancreatic cancer
Surgery
Surgical Oncology
Surgical outcomes
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Pancreatic fistula is one of the most common and potentially fatal surgical complications after radical gastrectomy. The purpose of this study was to assess the validity of extrapolating the definition of pancreatic fistula by the International Study Group on Pancreatic Surgery to include situations surrounding gastric cancer surgery. Methods The clinicopathological data of 443 patients who underwent elective gastrectomy with suprapancreatic lymph node dissection (D1+, D2, or D2+ dissection) without pancreatic resection were reviewed. The relationship between postoperative pancreas-related complications (PPRC) and laboratory data, including drain fluid amylase levels on postoperative day 1 (dAmy1) and day 3 (dAmy3), were investigated. Results Twenty-four patients (5.4%) developed PPRC of ≥ grade II according to Clavien–Dindo classification. Among them, 15 patients had dAmy3 levels ≥ 375 IU/L, while all 24 patients had dAmy1 levels ≥ 375 IU/L. None of the patients with dAmy1 levels 
ISSN:1341-9625
1437-7772
DOI:10.1007/s10147-022-02177-x